MedPath
TGA Approval

OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial (446150)

446150

OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial

Roche Products Pty Ltd

March 27, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a1e4426483966cef9ca6803266f266d0.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/bd02fa998954b66bb98b821deaab3c29.pdf

Active Ingredients

ocrelizumab

© Copyright 2025. All Rights Reserved by MedPath
OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial (446150) - TGA 批准文号 | MedPath